Manchester Bio-Community

Manchester is at the epicentre of biotechnology development and fast becoming the UK´s biggest and best biotech base.

Manchester Bio-community is the optimal environment for success in biotechnology and comprises:

o Four universities that provide world-leading teaching and research.

o Five university teaching hospitals and their associated clinical research centres.

o Numerous centres of excellence and intra-city and cross-regional bio-science networks and initiatives.

o Sector-specific experienced professional services, technology transfer and business support services

Biotech companies: Manchester is the ideal environment for the successful growth of biotech companies at all stages of development.

Biomedical establishments: Manchester’s biomedical sector includes several centres of excellence and provides access to world leading expertise, from research through to the clinic.

Specialist Enabling services & Facilities: Manchester Bio-community provides accommodation, innovation and business support services, and effective networks. An entrepreneurial culture encourages collaboration and facilitates the development and growth of bio-science commercial opportunities.

As a key member of the Northwest biotech cluster, Manchester bio-community is strongly supported by the Northwest Development Agency's sector group, Bionow.

To download the Manchester Bio-community map click here.

The Manchester Biotech Benefits

Tenants in UMIC’s Biotech facilities can benefit from:

• A relationship with The University of Manchester – the largest single site university in the UK

- Collaborative opportunities (commercial or research-based)

- Introduction to The University’s investment funds (Proof of Concept, Follow on Fund, Manchester Technology Fund)

- Access to modern hi-specification biotechnology incubation laboratories

- Links to any relevant initiatives such as the GMP Clean Room Unit (UK Centre for Tissue Regeneration/NW Embryonic Stem Cell Centre, the Manchester Cancer Centre; the Wellcome Trust Clinical Research Facility; and the NW Genetics Knowledge Park

- Access to the Manchester Momentum consortium of SMEs and companies that are associated with the University

- Access to Manchester Business School (ranked 22 in the world) and its virtual business incubator

• Links to relevant & high profile clinical activities

- Facilitation of relationships with major, R&D active, NHS Trusts in Manchester

- Facilitated access to relevant regional clinical units

- Access to NW regional patient base of 7 million (>3million in Greater Manchester region)

- Facilitated introduction to local ethics committee for clinical/translation projects

- New £40m Biomedical Research Centre (BMRC) – Manchester is in line for one of these 5 clinical centres in the UK, which will be the premier sites for clinical research in the UK

• Strong city and regional development support and connectivity

- Support for businesses relocating to the NW through the NW Regional Development Agency, BIONOW and/or MIDAS

- Business support and access to strong and diverse business associate network

- Convenient access to Manchester Airport - the UK’s third largest airport which currently handles 20 million passengers a year, offering direct flights to over 180 destinations worldwide by over 90 airlines

- Rail network – rapid links to the whole of the UK (only 2h15’ to London)